• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ALK-Abello A/S

+ Add to Watchlist


142.4190 USD 0.8310 0.58%

As of 20:10:00 ET on 08/11/2014.

Company Profile for ALK-Abello A/S (AKBLF)

Alk-Abello A/S produces pharmaceuticals for allergy vaccination. The Company is an international group with subsidiaries and associated companies worldwide.

Contact Information

ALK-Abello A/S

6-8 Boege Alle
Horsholm, 2970
Phone: 45-45-74-75-76
Fax: 45-45-74-86-07

Key Executives for ALK-Abello A/S (AKBLF)

Jens BagerPresident/CEOSoren NiegelExec VP:Commercial Operations
Flemming PedersenExec VP:Finance & IT/CFOHenrik JacobiExec VP:Research & Dev
Flemming Steen JensenExec VP:Product SupplyPer PlotnikofDirector:Investor Relations
Katja Barnkob ThalundSenior Project Mgr:CMCDorthe SeitzbergManager:Clinical Project Mgmt
Jacob KastrupProject Coordinator

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil